• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMF3838C150TU
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 08/04/2017
Type of Reportable Event Serious Injury
Event or Problem Description
A valiant captivia stent graft was implanted in the patient for the endovascular treatment of 60mm diameter thoracic aortic aneurysm.It was reported that the patient presented emergently under the care of another physician and was found to have a dissection extending proximally from the stent graft to the subclavian artery.The physician stated that they would medically manage the patient and determine if an lsa bypass is needed along with a proximal stent graft extension.Per the physician the cause of the event is due to uncontrolled hypertension.No additional clinical sequelae were reported and the patient will be monitored by their physician.
 
Additional Manufacturer Narrative
Film review summary: the exact cause of the dissection flap seen just above the proximal bare spring could not be determined from the post-implant films provided.The pre-implant anatomy is unknown and films during implant were not available.Ct¿s returned from 3 months post-implant revealed that a single valiant captivia stent graft had been implanted in the patient¿s descending thoracic.The proximal bare spring was positioned just past the aortic arch ~12cm caudal to the lsa, in an essentially straight segment of the descending thoracic.A thoracic dissection flap was seen extending ~15mm above the bare spring.It is possible that this dissection flap may have been related to a pre-existing anatomical condition, caused by the reported uncontrolled hypertension, or was possibly related to the implant of the stent graft.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - FF
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key6829545
Report Number2953200-2017-01355
Device Sequence Number1523058
Product Code MIH
UDI-Device Identifier00643169346956
UDI-Public00643169346956
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/06/2018
Device Model NumberVAMF3838C150TU
Device Catalogue NumberVAMF3838C150TU
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/05/2017
Supplement Date Received by Manufacturer11/08/2017
Initial Report FDA Received Date08/30/2017
Supplement Report FDA Received Date11/22/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Disability;
Patient Age83 YR
-
-